Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein-Tyrosine Kinases | 4 | 2019 | 95 | 1.870 |
Why?
|
Neoplasm Proteins | 4 | 2019 | 324 | 1.630 |
Why?
|
Breast Neoplasms | 5 | 2019 | 1179 | 1.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2019 | 828 | 0.780 |
Why?
|
Smad4 Protein | 1 | 2019 | 5 | 0.700 |
Why?
|
Mass Spectrometry | 3 | 2020 | 301 | 0.690 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 89 | 0.630 |
Why?
|
Phosphoproteins | 2 | 2014 | 108 | 0.550 |
Why?
|
RNA-Binding Proteins | 2 | 2014 | 123 | 0.530 |
Why?
|
Sin3 Histone Deacetylase and Corepressor Complex | 3 | 2020 | 3 | 0.520 |
Why?
|
Hydroxycholesterols | 2 | 2012 | 9 | 0.520 |
Why?
|
Proteome | 1 | 2016 | 173 | 0.490 |
Why?
|
Proteomics | 2 | 2020 | 330 | 0.490 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 428 | 0.460 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2012 | 203 | 0.450 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 117 | 0.430 |
Why?
|
Ketocholesterols | 1 | 2012 | 1 | 0.430 |
Why?
|
Histone Deacetylase 1 | 4 | 2020 | 8 | 0.420 |
Why?
|
Early Growth Response Protein 1 | 1 | 2012 | 35 | 0.420 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 1416 | 0.410 |
Why?
|
Carotid Stenosis | 1 | 2012 | 64 | 0.400 |
Why?
|
Apoptosis | 2 | 2012 | 1112 | 0.300 |
Why?
|
Genes, Tumor Suppressor | 2 | 2019 | 73 | 0.280 |
Why?
|
Phosphorylation | 3 | 2019 | 534 | 0.280 |
Why?
|
Repressor Proteins | 3 | 2020 | 153 | 0.240 |
Why?
|
HEK293 Cells | 4 | 2020 | 224 | 0.230 |
Why?
|
Protein Interaction Maps | 2 | 2020 | 23 | 0.220 |
Why?
|
Histone Deacetylase 2 | 2 | 2020 | 4 | 0.210 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 106 | 0.200 |
Why?
|
Signal Transduction | 3 | 2019 | 1622 | 0.190 |
Why?
|
Enzyme Assays | 1 | 2019 | 9 | 0.170 |
Why?
|
Ubiquitination | 1 | 2019 | 43 | 0.170 |
Why?
|
Tyrosine | 1 | 2019 | 95 | 0.170 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 48 | 0.170 |
Why?
|
Humans | 13 | 2020 | 50208 | 0.170 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 144 | 0.160 |
Why?
|
Female | 7 | 2019 | 26635 | 0.160 |
Why?
|
Tamoxifen | 1 | 2019 | 60 | 0.160 |
Why?
|
Breast | 1 | 2019 | 84 | 0.160 |
Why?
|
Molecular Chaperones | 1 | 2018 | 65 | 0.160 |
Why?
|
Chromatography, Affinity | 1 | 2018 | 38 | 0.150 |
Why?
|
Workflow | 1 | 2018 | 51 | 0.150 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 40 | 0.150 |
Why?
|
Estrogens | 1 | 2019 | 228 | 0.140 |
Why?
|
Research | 1 | 2016 | 109 | 0.130 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 166 | 0.130 |
Why?
|
Cell Line | 4 | 2020 | 1021 | 0.120 |
Why?
|
src Homology Domains | 1 | 2014 | 8 | 0.120 |
Why?
|
Green Fluorescent Proteins | 1 | 2014 | 91 | 0.110 |
Why?
|
Reactive Oxygen Species | 2 | 2012 | 408 | 0.110 |
Why?
|
src-Family Kinases | 1 | 2013 | 51 | 0.110 |
Why?
|
Lysosomes | 2 | 2010 | 84 | 0.110 |
Why?
|
U937 Cells | 1 | 2012 | 14 | 0.110 |
Why?
|
Cell Movement | 1 | 2014 | 249 | 0.110 |
Why?
|
DNA Methylation | 1 | 2017 | 550 | 0.100 |
Why?
|
Carcinoma | 1 | 2013 | 139 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2012 | 99 | 0.100 |
Why?
|
Protein Binding | 3 | 2020 | 665 | 0.100 |
Why?
|
Edetic Acid | 1 | 2010 | 14 | 0.090 |
Why?
|
Pyridoxal Phosphate | 1 | 2010 | 10 | 0.090 |
Why?
|
Genes, p53 | 1 | 2009 | 51 | 0.090 |
Why?
|
Cell Proliferation | 1 | 2014 | 1013 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2009 | 38 | 0.090 |
Why?
|
Immunohistochemistry | 1 | 2012 | 978 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2019 | 56 | 0.080 |
Why?
|
Cell Nucleus | 2 | 2020 | 187 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2020 | 487 | 0.080 |
Why?
|
Mitochondria | 1 | 2010 | 404 | 0.070 |
Why?
|
Animals | 2 | 2019 | 13246 | 0.050 |
Why?
|
Mice | 1 | 2012 | 5759 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2020 | 6 | 0.050 |
Why?
|
Multigene Family | 1 | 2020 | 56 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2020 | 119 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2020 | 51 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 225 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 143 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 586 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 231 | 0.040 |
Why?
|
Protein Subunits | 1 | 2018 | 77 | 0.040 |
Why?
|
HeLa Cells | 1 | 2018 | 260 | 0.040 |
Why?
|
Immunoblotting | 1 | 2017 | 117 | 0.040 |
Why?
|
CpG Islands | 1 | 2017 | 107 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 106 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 454 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 475 | 0.030 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 14 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 378 | 0.030 |
Why?
|
Neoplasm Grading | 1 | 2013 | 123 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 253 | 0.030 |
Why?
|
Transfection | 1 | 2013 | 355 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 186 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 28 | 0.020 |
Why?
|
Cathepsin L | 1 | 2009 | 2 | 0.020 |
Why?
|
Ferritins | 1 | 2009 | 30 | 0.020 |
Why?
|
Cell Death | 1 | 2010 | 182 | 0.020 |
Why?
|
DNA Damage | 1 | 2009 | 301 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 1294 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2010 | 771 | 0.020 |
Why?
|
Aged | 1 | 2009 | 9405 | 0.010 |
Why?
|
Middle Aged | 1 | 2009 | 12206 | 0.010 |
Why?
|
Male | 1 | 2009 | 25399 | 0.010 |
Why?
|